I agree that this site is using cookies. You can find further informations here.
X
Mouw, Kent W.
196  results:
Search for persons X
?
1

DNA repair deficiency and the immune microenvironment: A pa..:

Zhou, Yuzhen ; Mouw, Kent W.
DNA Repair.  133 (2024)  - p. 103594 , 2024
Link: https://doi.org/10.1016/..
 
?
2

Ensuring Successful Biomarker Studies in Bladder Preservati..:

McConkey, David J. ; Baumann, Brian C. ; Cooper Greenberg, Stephanie...
Bladder Cancer.  10 (2024)  1 - p. 1-8 , 2024
Link: https://doi.org/10.3233/..
 
?
3

SABR Today . . . and Tomorrow?:

Tran, Phuoc T. ; Mouw, Kent W.
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  1 - p. 11 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Insulin resistance during androgen deprivation therapy in m..:

Basaria, Shehzad ; Taplin, Mary‐Ellen ; McDonnell, Marie...
Cancer.  , 2024
Link: https://doi.org/10.1002/..
 
?
5

The Next Chapter in Immunotherapy and Radiation Combination..:

Wisdom, Amy J. ; Barker, Christopher A. ; Chang, Joe Y....
International Journal of Radiation Oncology*Biology*Physics.  118 (2024)  5 - p. 1404-1421 , 2024
Link: https://doi.org/10.1016/..
 
?
6

Activity of Enfortumab Vedotin and Sacituzumab Govitecan wi..:

Zhou, Yuzhen ; D'Andrea, Vincent D. ; Shanmugam, Surish P....
European Urology.  86 (2024)  1 - p. 69-71 , 2024
Link: https://doi.org/10.1016/..
 
?
7

Author Correction: Gemcitabine and cisplatin plus nivolumab..:

Galsky, Matthew D. ; Daneshmand, Siamak ; Izadmehr, Sudeh...
Nature Medicine.  30 (2024)  4 - p. 1211-1211 , 2024
Link: https://doi.org/10.1038/..
 
?
8

Prognostic Significance of Immune Cell Infiltration in Musc..:

Rana, Zaker ; Kamran, Sophia C. ; Shetty, Amol C....
European Urology Oncology.  , 2024
Link: https://doi.org/10.1016/..
 
?
9

CRISPR screens reveal genetic determinants of PARP inhibito..:

Tsujino, Takuya ; Takai, Tomoaki ; Hinohara, Kunihiko...
Nature Communications.  14 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
10

Development of PARP Inhibitors in Targeting Castration-Resi..:

, In: Targeting the DNA Damage Response for Cancer Therapy; Cancer Treatment and Research,
Mouw, Kent W. ; Choudhury, Atish D. - p. 103-124 , 2023
Link: https://doi.org/10.1007/..
 
?
11

Gemcitabine and cisplatin plus nivolumab as organ-sparing t..:

Galsky, Matthew D. ; Daneshmand, Siamak ; Izadmehr, Sudeh...
Nature Medicine.  29 (2023)  11 - p. 2825-2834 , 2023
Link: https://doi.org/10.1038/..
 
?
12

Genomic Tumor Correlates of Clinical Outcomes Following Org..:

Kamran, Sophia C. ; Zhou, Yuzhen ; Otani, Keisuke...
Clinical Cancer Research.  29 (2023)  24 - p. 5116-5127 , 2023
Link: https://doi.org/10.1158/..
 
?
13

Nucleotide excision repair deficiency is a targetable thera..:

Prosz, Aurel ; Duan, Haohui ; Tisza, Viktoria...
Scientific Reports.  13 (2023)  1 - p. , 2023
Link: https://doi.org/10.1038/..
 
?
14

Bladder preservation after neoadjuvant therapy – 2021 IBCN ..:

Hensley, Patrick J. ; Seiler, Roland ; Herr, Harry...
Urologic Oncology: Seminars and Original Investigations.  41 (2023)  7 - p. 307-312 , 2023
Link: https://doi.org/10.1016/..
 
?
15

Sequential intravesical gemcitabine/docetaxel provides a du..:

Yim, Kendrick ; Melnick, Kevin ; Mott, Sarah L....
Urologic Oncology: Seminars and Original Investigations.  41 (2023)  11 - p. 458.e1-458.e7 , 2023
Link: https://doi.org/10.1016/..
 
1-15